Our previous finding validated the tumor suppressor role of AGT in breast cancer cells, which prompted us to clarify whether suppression of AGT elicited by high glucose treatment predominantly contributed to its pro-tumoral effects. The gene discussed is AGT; the disease is breast cancer.